Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Jul;63(7):870–873. doi: 10.1136/ard.2003.011692

Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study

F Moosig 1, N Czech 1, C Mehl 1, E Henze 1, R Zeuner 1, M Kneba 1, J Schroder 1
PMCID: PMC1755055  PMID: 15194587

Abstract

Objective: To quantify 18-fluorodeoxyglucose (FDG) accumulation in large vessels in patients with polymyalgia rheumatica by positron emission tomography (PET), and to compare these data with serological markers of inflammation.

Methods: 13 untreated patients with active polymyalgia rheumatica underwent FDG positron emission tomography; eight were analysed in a second PET when in clinical remission. Six patients with other highly inflammatory conditions served as controls. For quantitative analysis, FDG uptake over nine defined vascular regions, divided by an individual background value, was expressed as a region of interest (ROI) index. These data were compared with the clinical status of the patient and with erythrocyte sedimentation rate (ESR), C reactive protein, haemoglobin, and platelet and leucocyte counts.

Results: By visual evaluation, 12 of the 13 patients showed an increased tracer uptake of the aorta or its major branches. By quantitative analysis, FDG uptake was significantly increased in polymyalgia rheumatica. In patients with active disease, the mean ROI index for all vascular regions exceeded that of controls by 70% (mean (SD): 1.58 (0.37) v 0.93 (0.12); p<0.001). In the eight patients who underwent follow up PET, the index declined substantially. In active polymyalgia rheumatica, FDG uptake was significantly correlated with C reactive protein (r = 0.8), ESR (r = 0.79), and platelet counts (r = 0.68).

Conclusions: The observed FDG accumulation in the aorta and its branches and a strong correlation between tracer uptake and markers of inflammation is suggestive of large vessel arteritis. Quantitative ROI analysis appears to be a sensitive tool for detecting such inflammation.

Full Text

The Full Text of this article is available as a PDF (79.3 KB).

Figure 1.

Figure 1

Open in a new tab

 Normalisation of tracer uptake in a patient with polymyalgia rheumatica (PMR) on steroid treatment.

Figure 2.

Figure 2

Open in a new tab

 Mean region of interest (ROI) index for the subclavian arteries in patients with polymyalgia rheumatica and controls; a, active disease; c, control; r, remission. *p<0.01; **p<0.001.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blockmans D., Maes A., Stroobants S., Nuyts J., Bormans G., Knockaert D., Bobbaers H., Mortelmans L. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999 May;38(5):444–447. doi: 10.1093/rheumatology/38.5.444. [DOI] [PubMed] [Google Scholar]
  2. Blockmans D., Stroobants S., Maes A., Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000 Feb 15;108(3):246–249. doi: 10.1016/s0002-9343(99)00424-6. [DOI] [PubMed] [Google Scholar]
  3. Hamrin B., Jonsson N., Hellsten S. "Polymyalgia arteritica". Further clinical and histopathological studies with a report of six autopsy cases. Ann Rheum Dis. 1968 Sep;27(5):397–405. doi: 10.1136/ard.27.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Marzo-Ortega H., McGonagle D., O'Connor P., Pease C., Emery P. Subclinical vasculitis in polymyalgia rheumatica. Ann Rheum Dis. 2001 Nov;60(11):1058–1059. doi: 10.1136/ard.60.11.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Salvarani Carlo, Cantini Fabrizio, Boiardi Luigi, Hunder Gene G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002 Jul 25;347(4):261–271. doi: 10.1056/NEJMra011913. [DOI] [PubMed] [Google Scholar]
  6. Salvarani Carlo, Silingardi Mauro, Ghirarduzzi Angelo, Lo Scocco Giovanni, Macchioni PierLuigi, Bajocchi GianLuigi, Vinceti Marco, Cantini Fabrizio, Iori Ido, Boiardi Luigi. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Ann Intern Med. 2002 Aug 20;137(4):232–238. doi: 10.7326/0003-4819-137-4-200208200-00006. [DOI] [PubMed] [Google Scholar]
  7. Schmidt W. A., Kraft H. E., Vorpahl K., Völker L., Gromnica-Ihle E. J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997 Nov 6;337(19):1336–1342. doi: 10.1056/NEJM199711063371902. [DOI] [PubMed] [Google Scholar]
  8. Turlakow A., Yeung H. W., Pui J., Macapinlac H., Liebovitz E., Rusch V., Goy A., Larson S. M. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med. 2001 Apr 9;161(7):1003–1007. doi: 10.1001/archinte.161.7.1003. [DOI] [PubMed] [Google Scholar]
  9. Weyand C. M., Hicok K. C., Hunder G. G., Goronzy J. J. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994 Oct 1;121(7):484–491. doi: 10.7326/0003-4819-121-7-199410010-00003. [DOI] [PubMed] [Google Scholar]
  10. Weyand C. M., Tetzlaff N., Björnsson J., Brack A., Younge B., Goronzy J. J. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 1997 Jan;40(1):19–26. doi: 10.1002/art.1780400105. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES